93H-31864-03625
1 vaccination
4 coded responses
11 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 027 / MA
- Registered
- 2021-10-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-10-24
Dose 1 — Pfizer-BioNTech
-
2021-10-29
Registered in v-safe
-
2021-10-29
Survey response — days 1–6 daily, dose 1MedDRA: Abnormal dreams, Hyperacusis — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Hyperacusis, vivid dreamsMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Survey response — days 1–6 daily, dose 1MedDRA: Hyperacusis, Lymphadenopathy, Pharyngeal swelling, Rash, Tinnitus — Feeling: Poor · Site: Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Hyperacusis, tinnitus, rash on torso face and neck with throat and lymph node swellingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-31
Survey response — day 7, dose 1MedDRA: Angioedema, Hyperacusis, Hypoaesthesia — Feeling: Poor · Site: Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Hyperacusis, angioedema involving face neck and abdomen, facial numbness on left side of faceMedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Call successfulParticipant prefers to complete VAERS report online
- 2021-11-07
- 2021-11-14
- 2021-11-21
-
2021-11-28
Survey response — day 35, dose 1MedDRA: Condition aggravated, Hypoaesthesia, Lacrimation increased, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I had a previous bout of Bell's palsy from Lyme disease a few years ago and since stopping the steroids for angioedema I'm noticing the Bell's palsy symptoms are back- can't feel the left side of my face and neck and my eye won't stop tearing upMedDRA releases: 2024-11 · check-in free text available
-
2021-11-28
Report sent to call center — day 35, dose 1Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-29
- 2021-11-30
- 2021-12-01
-
2021-12-01
Call successfulReported to VAERS during previous contact from GDIT
- 2021-12-05
- 2022-01-23
- 2022-04-24
- 2022-10-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-10-24 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
VAERS report filed, before or during a call: 1
Free text
Release 10 — days 1–6 daily, dose 1
Systemic reaction (other): Hyperacusis, vivid dreams
Systemic reaction (other): Hyperacusis, tinnitus, rash on torso face and neck with throat and lymph node swelling
Release 10 — day 7, dose 1
Systemic reaction (other): Hyperacusis, angioedema involving face neck and abdomen, facial numbness on left side of face
Release 10 — day 35, dose 1
Symptoms: I had a previous bout of Bell's palsy from Lyme disease a few years ago and since stopping the steroids for angioedema I'm noticing the Bell's palsy symptoms are back- can't feel the left side of my face and neck and my eye won't stop tearing up
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | · | · | ✓ |
| SD | Hypoaesthesia | · | · | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Abnormal dreams | · | · | ✓ |
| SRO | Angioedema | · | · | ✓ |
| SRO | Hyperacusis | · | · | ✓ |
| SRO | Hypoaesthesia | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Pharyngeal swelling | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Tinnitus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release